Neuropsychiatric Symptoms and the Diagnostic Stability of Mild Cognitive Impairment.

BACKGROUND Mild cognitive impairment (MCI) is an intermediate diagnosis between normal cognition (NC) and dementia, including Alzheimer's disease (AD) dementia. However, MCI is heterogeneous; many individuals subsequently revert to NC while others remain stable at MCI for several years. Identifying factors associated with this diagnostic instability could assist in defining clinical populations and determining cognitive prognoses. OBJECTIVE The current study examined whether neuropsychiatric symptoms could partially account for the temporal instability in cognitive diagnoses. METHOD The sample included 6,763 participants from the National Alzheimer's Coordinating Center Uniform Data Set. All participants had NC at baseline, completed at least two follow-up visits (mean duration: 5.5 years), and had no recent neurological conditions. Generalized linear models estimated by generalized estimating equations examined associations between changes in cognitive diagnoses and symptoms on the Neuropsychiatric Inventory Questionnaire (NPI-Q) and Geriatric Depression Scale (GDS-15). RESULTS 1,121 participants converted from NC to MCI; 324 reverted back to NC and 242 progressed to AD dementia. Higher symptoms on the GDS-15 and circumscribed symptom domains on the NPI-Q were associated with conversion from NC to MCI and a decreased likelihood of reversion from MCI to NC. Individuals with higher symptoms on NPI-Q Hyperactivity and Mood items were more likely to progress to AD dementia. DISCUSSION The temporal instability of MCI can be partially explained by neuropsychiatric symptoms. Individuals with higher levels of specific symptoms are more likely to progress to AD dementia and less likely to revert to NC. Identification and treatment of these symptoms might support cognitive functioning in older adults.

[1]  M. Cesari,et al.  Spontaneous Reversion of Mild Cognitive Impairment to Normal Cognition: A Systematic Review of Literature and Meta-Analysis. , 2016, Journal of the American Medical Directors Association.

[2]  M. Nehls Unified theory of Alzheimer’s disease (UTAD): implications for prevention and curative therapy , 2016, Journal of molecular psychiatry.

[3]  M. Malek-Ahmadi,et al.  Reversion From Mild Cognitive Impairment to Normal Cognition: A Meta-Analysis , 2016, Alzheimer disease and associated disorders.

[4]  Eric E. Smith,et al.  Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment , 2016, Alzheimer's & Dementia.

[5]  Jeannie-Marie S. Leoutsakos,et al.  Patterns of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Risk of Dementia. , 2016, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[6]  M. Weiner,et al.  Predictors of Reversion from Mild Cognitive Impairment to Normal Cognition , 2017, Dementia and Geriatric Cognitive Disorders.

[7]  D. Challis,et al.  Translating cognitive and everyday activity deficits into cognitive interventions in mild dementia and mild cognitive impairment , 2015, International journal of geriatric psychiatry.

[8]  T. Yen,et al.  Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  V. Pankratz,et al.  Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal , 2014, Neurology.

[10]  G. Andersson,et al.  A Meta-Analysis of Cognitive-Behavioural Therapy for Adult Depression, Alone and in Comparison with other Treatments , 2013, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[11]  P. Regal,et al.  Neurologic manifestations of E coli infection–induced hemolytic-uremic syndrome in adults , 2013, Neurology.

[12]  P. Sachdev,et al.  Factors Predicting Reversion from Mild Cognitive Impairment to Normal Cognitive Functioning: A Population-Based Study , 2013, PloS one.

[13]  J. Pantel,et al.  Send Orders of Reprints at Bspsaif@emirates.ae Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease , 2022 .

[14]  Thomas D Koepsell,et al.  Reversion from mild cognitive impairment to normal or near-normal cognition , 2012, Neurology.

[15]  J. Dartigues,et al.  Benzodiazepine use and risk of dementia: prospective population based study , 2012, BMJ : British Medical Journal.

[16]  I. Kirsch,et al.  A Systematic Review of Comparative Efficacy of Treatments and Controls for Depression , 2012, PloS one.

[17]  K. Blennow,et al.  Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. , 2012, The American journal of psychiatry.

[18]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[19]  E. McAuley,et al.  Exercise training increases size of hippocampus and improves memory , 2011, Proceedings of the National Academy of Sciences.

[20]  James R. Burke,et al.  Systematic Review: Factors Associated With Risk for and Possible Prevention of Cognitive Decline in Later Life , 2010, Annals of Internal Medicine.

[21]  C. Caltagirone,et al.  Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy. , 2010, Journal of Alzheimer's disease : JAD.

[22]  H. Gertz,et al.  Anosognosia in Alzheimer’s disease: The role of impairment levels in assessment of insight across domains , 2010, Journal of the International Neuropsychological Society.

[23]  Bradley N Gaynes,et al.  Prescription refill records as a screening tool to identify antidepressant non‐adherence , 2010, Pharmacoepidemiology and drug safety.

[24]  D. Lawlor,et al.  Exercise for depression. , 2009, The Cochrane database of systematic reviews.

[25]  A. Mitchell,et al.  Rate of progression of mild cognitive impairment to dementia – meta‐analysis of 41 robust inception cohort studies , 2009, Acta psychiatrica Scandinavica.

[26]  Nathaniel Mercaldo,et al.  The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery , 2009, Alzheimer disease and associated disorders.

[27]  Ruth O'Hara,et al.  Late-life anxiety and cognitive impairment: a review. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[28]  Hans-Jürgen Möller,et al.  Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. , 2008, Journal of psychiatry & neuroscience : JPN.

[29]  Jennifer D. Davis,et al.  Neuropsychological Correlates of Self-Reported Depression and Self-Reported Cognition Among Patients With Mild Cognitive Impairment , 2008, Journal of geriatric psychiatry and neurology.

[30]  E. Teng,et al.  Neuropsychiatric Symptoms Are Associated with Progression from Mild Cognitive Impairment to Alzheimer’s Disease , 2007, Dementia and Geriatric Cognitive Disorders.

[31]  Joylee Wu,et al.  The National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data Set , 2007, Alzheimer disease and associated disorders.

[32]  Nick C Fox,et al.  Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study , 2007, The Lancet Neurology.

[33]  J. Morris,et al.  The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease Centers , 2006, Alzheimer disease and associated disorders.

[34]  Søren Højsgaard,et al.  The R Package geepack for Generalized Estimating Equations , 2005 .

[35]  R. Doody,et al.  Accuracy of Self‐Reported Depression in Persons with Dementia , 2005, Journal of the American Geriatrics Society.

[36]  B. Ravnkilde,et al.  Hippocampal volume and depression: a meta-analysis of MRI studies. , 2004, The American journal of psychiatry.

[37]  Woodrow D. Deitrich,et al.  The National Alzheimer's Coordinating Center (NACC) Database: An Alzheimer Disease Database , 2004, Alzheimer disease and associated disorders.

[38]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[39]  J. Cummings,et al.  Mild Cognitive Impairment is Associated With Characteristic Neuropsychiatric Symptoms , 2004, Alzheimer disease and associated disorders.

[40]  J. Becker,et al.  Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease. , 2003, The Journal of neuropsychiatry and clinical neurosciences.

[41]  Jelle Jolles,et al.  Behavioral Problems in Dementia: A Factor Analysis of the Neuropsychiatric Inventory , 2003, Dementia and Geriatric Cognitive Disorders.

[42]  Eric J. Nestler,et al.  Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus , 2000, The Journal of Neuroscience.

[43]  B. Pollock,et al.  Changes in cognitive functioning following treatment of late-life depression. , 2000, The American journal of psychiatry.

[44]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[45]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[46]  G. Box,et al.  Transformation of the Independent Variables , 1962 .

[47]  Jeannie-Marie S. Leoutsakos,et al.  Latent Classes of Neuropsychiatric Symptoms in NACC Controls and Conversion to Mild Cognitive Impairment or Dementia. , 2015, Journal of Alzheimer's disease : JAD.

[48]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[49]  Hannah R. Snyder Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. , 2013, Psychological bulletin.

[50]  R. Petersen,et al.  Cognitive Impairment : An Overview By , 2013 .

[51]  A. Levey,et al.  Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers. , 2012, Journal of Alzheimer's disease : JAD.

[52]  J. Csernansky,et al.  Effects of stress and stress hormones on amyloid-beta protein and plaque deposition. , 2009, Journal of Alzheimer's disease : JAD.

[53]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[54]  D. Lawlor,et al.  Exercise for Depression. , 1978, The Physician and sportsmedicine.